#

Reviewed by Prof. Martin Fredensborg Rath

Professor of Experimental Neuroanatomy, Dept. of Neuroscience, University of Copenhagen

Click here: Understand the involvement of the basal ganglia in Parkinson’s disease

file_download Download in HQ
Published 15.03.2022
Permissions
Published 15.03.2022
Permissions

Related content

grid_view Slide Deck
Major depressive disorder (MDD) – Definitions and Diagnosis

This slide deck offers a comprehensive overview of Major Depressive Disorder (MDD), including its definitions, diagnostic criteria, symptom profiles, clinical course, differential diagnoses, and validated rating tools based on DSM-5-TR and ICD-11 guidelines.

02.07.2025 Depression
image Image Graphic showing extracellular, multimerization, and intracellular targets of alpha-synuclein for therapeutic intervention in Parkinson’s disease
Possible α-synuclein targets for development of therapies for Parkinson’s disease

Overview of three therapeutic strategies targeting alpha-synuclein in the development of disease-modifying treatments for Parkinson’s disease

26.06.2025 Parkinson’s Disease
image Image Chart showing progression of functional decline in Parkinson’s disease with different treatment approaches, from symptomatic benefit to disease modification.
Disease modification in Parkinson’s disease

Graphical representation of how various treatment strategies can impact disease progression in Parkinson’s disease, from symptom relief to potential cure

26.06.2025 Parkinson’s Disease